View Post

Visit of the IRCI and the ARSACS project

In Latest News by ARSACS

On June 11th, thanks to Manon Valiquette, Sonia Gobeil representing the Foundation had the pleasure of visiting the Institute for Research in Immunology and Cancer (IRCI) in Montreal and discovering extraordinary people who are very passionate about their work. Their ARSACS project consists in optimizing active molecules aimed at producing a reversal of the ARSACS phenotype in an In Vivo …

View Post

Working together to achieve our common goals

In Latest News by ARSACS

The acronym “ARSACS” enters the life of Susanna de Luca and Paolo Arrigoni when their young child was diagnosed with ARSACS. Paolo joined the Board of Directors of the Ataxia Charlevoix-Saguenay Foundation in 2018 and, after having participated in the international symposium on ARSACS in Montreal, concluded that a point of reference and support was necessary in Europe, especially since …

View Post

Dr. Brais at the 6th International Meeting on Spastic Paraparesis and Ataxia

In Latest News by ARSACS

Dr. Brais will be presenting “New insights on ARSACS lead to a search for candidate compounds“ at the 6th International Meeting on Spastic Paraparesis and Ataxia on September 20-21 2019 in Nice, France. The program includes plenary talks from leaders in the field of spinocerebellar diseases (dominant and recessive forms of cerebellar ataxias and spastic paraplegias) Interesting, right? Share with …

View Post

Dr. Synofzik's ARSACS study to be published in the Journal of Neurology

In Latest News by ARSACS

“Speech treatment improves dysarthria in multisystemic ataxia: a raterblinded, controlled pilot-study in ARSACS” research study done by Dr. Synofzik and his research team to be published in the Journal of Neurology. To learn more about the study, interested readers can contact Dr. Matthis Synofzik directly. See Abstract Interesting, right? Share with your friends & followers / Intéressant, non? Partagez avec …

View Post

EMG data obtained from 35 ARSACS individuals

In Latest News by ARSACS

EMG data of 6 muscles from 35 ARSACS patients were obtained as part of Dr. Luc J. Hébert’s ARSACS research project. The analysis of these EMG data will help to better understand the problem of spasticity in ARSACS patients and could eventually open the door to new interventions targeted more on these neuro- locomotive deficiences. Interesting, right? Share with your …

View Post

Learning from the UNC Catalyst for Rare Diseases

In Latest News by ARSACS

The University of North Carolina (UNC) Catalyst for Rare Diseases, funded in 2016, was established as a precompetitive open research group with a mission to understand the functional phenotic manifestations of genetic mutations. This article describes the initial experiences and learning from the UNC Catalyst for Rare diseases. Interesting, right? Share with your friends & followers / Intéressant, non? Partagez …